Emulation of the KEYNOTE-189 Trial Using Electronic Health Records

CompletedOBSERVATIONAL

Enrollment

1,854

Participants

Timeline

Start Date

June 5, 2023

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions

Non-small Cell Lung CancerMetastatic Lung Cancer

Interventions

DRUG

Pembrolizumab + Pemetrexed-Platinum

Medication records in EHR database used to define exposure group

DRUG

Pemetrexed-Platinum

Medication records in EHR database used to define comparator group

Trial Locations (1)

Aetion, Boston

All Listed Sponsors

lead

Aetion, Inc.

OTHER

NCT05908799 - Emulation of the KEYNOTE-189 Trial Using Electronic Health Records | Biotech Hunter | Biotech Hunter